We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$4.71B
AUM Growth
+$53M
Cap. Flow
-$971M
Cap. Flow %
-20.64%
Top 10 Hldgs %
15.17%
Holding
850
New
129
Increased
145
Reduced
185
Closed
179

Sector Composition

Rank Sector Weight
1 Financials 25.53%
2 Technology 16.39%
3 Healthcare 9.58%
4 Industrials 6.86%
5 Consumer Discretionary 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RENEW
576
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$80.1K ﹤0.01%
2,397,500
FOXO
577
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$80K ﹤0.01%
+957
New +$110K
IRAAW
578
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$75.1K ﹤0.01%
875,817
FAASW
579
DELISTED
DigiAsia Corp Warrant
FAASW
$72.2K ﹤0.01%
782,330
SLAMW
580
DELISTED
Slam Corp. warrant
SLAMW
$65.3K ﹤0.01%
283,750
OTMO
581
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$55K ﹤0.01%
+7,705
New +$56.4K
VLTA.WS
582
DELISTED
Volta Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
VLTA.WS
$53.8K ﹤0.01%
+250,000
New +$47.2K
AIOS
583
AIOS Tech
AIOS
$38.8M
$50.4K ﹤0.01%
526
-35
-6% -$3.86K
BIOR
584
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$45.4K ﹤0.01%
+1,640
New +$55.6K
HEPS
585
D-Market Electronic Services & Trading
HEPS
$1.04B
$43.1K ﹤0.01%
32,200
HZON.WS
586
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
$42.7K ﹤0.01%
90,943
EVE.WS
587
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$40.3K ﹤0.01%
806,620
API
588
Agora
API
$337M
$39.8K ﹤0.01%
11,000
LCW.WS
589
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
$39.1K ﹤0.01%
1,713,500
SDSTW
590
Stardust Power Inc Warrant
SDSTW
$4.93M
$34.1K ﹤0.01%
158,740
SLVRW
591
DELISTED
SilverSPAC Inc. Warrant
SLVRW
$33.3K ﹤0.01%
158,332
AEON.WS
592
DELISTED
AEON Biopharma Inc
AEON.WS
$32.8K ﹤0.01%
596,666
FIP icon
593
FTAI Infrastructure
FIP
$473M
$31.5K ﹤0.01%
10,500
WAVC.WS
594
DELISTED
Waverley Capital Acquisition Corp. 1 Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
WAVC.WS
$31.3K ﹤0.01%
333,333
THCPW
595
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$30K ﹤0.01%
166,700
JUN.WS
596
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$29.7K ﹤0.01%
296,912
-10,525
-3% -$1.78K
ZCARW
597
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$28.1K ﹤0.01%
324,999
BCSAW
598
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$28K ﹤0.01%
249,700
TLSA icon
599
Tiziana Life Sciences
TLSA
$123M
$27.8K ﹤0.01%
25,491
-20,500
-45% -$13.4K
ABPWW
600
DELISTED
Abpro Holdings Warrant
ABPWW
$26.2K ﹤0.01%
375,000

Similar funds

Cantor Fitzgerald's Q1 2023 Portfolio in Review

As of Q1 2023, Cantor Fitzgerald held 850 positions worth $4.71B, up 1.1% from $4.65B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Cantor Fitzgerald withdrew a net $971M in Q1 2023, closing 179 positions and reducing 185 holdings. Its most notable exit was AstraZeneca, an estimated $37.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Cantor Fitzgerald opened a new position in Zimmer Biomet worth $19.8M.

  • Cantor Fitzgerald's largest Q1 2023 buy was Zimmer Biomet: 153,493 shares worth $19.8M.
  • Cantor Fitzgerald added most to Battery Future Acquisition Corp. in Q1 2023, an estimated $28.6M increase.
  • Cantor Fitzgerald's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $935M.
  • Cantor Fitzgerald fully exited AstraZeneca in Q1 2023, selling an estimated $37.6M.
  • Cantor Fitzgerald's ten largest holdings make up 15% of its $4.71B portfolio in Q1 2023.
  • Cantor Fitzgerald opened 129 new positions and closed 179 in Q1 2023.
  • Cantor Fitzgerald's portfolio value rose 1.1% quarter-over-quarter to $4.71B.

Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.